This website uses cookies to enhance the user experience.
A

AQUAMEDIC AS997 770 765

Research
Limited company
Hans Egedes vei 7 1470 LØRENSKOG, Norge

AQUAMEDIC AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
12 years
since Jan 2, 2012
Type
Limited company
VAT registered
Yes
Number of employees
6

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
5
persons

Financials

Total operating income 2023
5,908,049
NOK
Annual total result 2023
-274,500
NOK
Total equity 2023
5,177,989
NOK
Last update: Oct 7, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
37.5 %
directly

Board

NameRoleShares
Chairman
37.5 %
directly
Deputy Chair
25 %
directly
Board Member
12.5 %
directly
Alternate Member
12.5 %
directly
Alternate Member
12.5 %
directly
Alternate Member-

Others

NameRoleShares
R
REVISJONSSENTERET AS
Auditor-
E
EFFECTUS REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
37.5 %
directly
Deputy Chair
25 %
directly
Alternate Member
12.5 %
directly
Board Member
12.5 %
directly
Alternate Member
12.5 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
37,500
37.5 %
Ordinary shares
25,000
25 %
Ordinary shares
12,500
12.5 %
Ordinary shares
12,500
12.5 %
Ordinary shares
12,500
12.5 %

Shares owned by the AQUAMEDIC AS

NameShare classNumber of sharesShare
A
ARCTIC FEED INGREDIENTS AS
Ordinary shares
718,691
35.6 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
5,908,049
8,531,678
6,452,112
Annual Total Result
-274,500
1,210,489
630,006
Total assets
7,185,586
7,048,428
5,768,874
Total liabilities
2,007,597
1,595,940
1,260,879
Total equity
5,177,989
5,452,489
4,507,995

P&L

Year202320222021
Total operating income
5,908,049
8,531,678
6,452,112
Total operating costs
5,902,625
7,400,748
5,451,343
Operating result
5,424
1,130,930
1,000,769
Financial income/costs
-75,340
143,669
-126,812
Profit before tax
-69,916
1,274,599
873,957
Total tax & extraordinary income/cost
204,584
64,110
243,951
Annual Total Result
-274,500
1,210,489
630,006

Balance overview

Year202320222021
Total fixed assets
963,582
1,157,841
1,254,692
Total current assets
6,222,004
5,890,587
4,514,182
Total assets
7,185,586
7,048,428
5,768,874
Short term debt
893,300
1,594,648
1,260,879
Long term debt
1,114,297
1,292
0
Total liabilities
2,007,597
1,595,940
1,260,879
Contributed capital
100,000
100,000
100,000
Retained earnings
5,077,989
5,352,489
4,407,995
Total equity
5,177,989
5,452,489
4,507,995
Total equity and liabilities
7,185,586
7,048,428
5,768,874

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology